Zimmer Biomet Hits Day Low of $85.84 Amid Price Pressure

Zimmer Biomet Holdings, Inc. has experienced significant volatility today, with the stock hitting an intraday low of USD 85.84. The company, which operates in the Pharmaceuticals & Biotechnology sector, has seen its stock price decline by 15.15% as of November 5, 2025. This sharp drop contrasts with the S&P 500's performance, which is down only 1.17% for the same day.
Over the past week, Zimmer Biomet's stock has decreased by 12.2%, and its performance over the last month shows a decline of 13.13%. Year-to-date, the stock is down 17.12%, while its one-year performance reflects a notable decrease of 19.62%. The company has consistently underperformed against the S&P 500 over the last three years, with a return of -16.5% compared to the benchmark's 79.59%.

Financial metrics indicate challenges, including a net profit decline of 28.26% over the past nine months and a high debt-equity ratio of 56.01%. Despite these hurdles, Zimmer Biomet maintains a high institutional ownership rate of 99.22%, suggesting a strong interest from larger investors.